Nagler, A, Labopin, M, Swoboda, R, Blaise D, Angelucci E, Vydra J, et al. Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2024. https://doi.org/10.1038/s41409-024-02400-5

Esquirol A, Pascual MJ, Kwon M, Pérez A, Parody R, Ferra C, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transpl. 2021;56:2432–44.

Article  CAS  Google Scholar 

G Little JS, Duléry R, Shapiro RM, Aleissa MM, Prockop SE, Koreth J, et al. Opportunistic infections in patients receiving post-transplantation cyclophosphamide: impact of haploidentical versus unrelated donor allograft. Transpl Cell Ther. 2024;30:233.e1–233.e14.

Article  Google Scholar 

Modi D, Kim S, Shatta M, Deol A, Kin A, Ayash L, et al. Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis. Bone Marrow Transpl. 2024;59:1196–8.

Article  CAS  Google Scholar 

DeZern AE, Franklin C, Tsai HL, Imus PH, Cooke KR, Varadhan R, et al. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2021;5:1360–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abid MB, Estrada-Merly N, Zhang MJ, Chen K, Allan D, Bredeson C, et al. Impact of donor age on allogeneic hematopoietic cell transplantation outcomes in older adults with acute myeloid leukemia. Transpl Cell Ther. 2023;29:578.e1–578.e9.

Article  Google Scholar 

Hamerschlak N, Gómez-Almaguer D, McLornan DP. Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation. Front Oncol. 2023;13:1321334.

Article  PubMed  PubMed Central  Google Scholar 

Nagler A, Labopin M, Arat M, Reményi P, Koc Y, Blaise D, et al. Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT. Cancer 2022;128:3959–68.

Article  CAS  PubMed  Google Scholar